Osteoporosis
Musculoskeletal·MeSH: Osteoporosis
Prevalence
7000.0 / 100K
Incidence
300.0 / 100K/yr
28 drugs in development·14 companies·12 clinical trials
Drug Pipeline by Phase
Approved(6)
Phase 3(7)
Phase 2(6)
Phase 1(1)
Unknown(1)
| Drug | Company |
|---|---|
| HLX14 | Organon & Co. (OGN) |
BLA Filed(1)
| Drug | Company |
|---|---|
| pf708 | Pfenex Inc. (PFNX) |
Phase 4(6)
Compare drugs
Frequently asked questions
How many drugs are in development for Osteoporosis?
BioSniper tracks 28 drugs in development for Osteoporosis across 14 companies.
How many clinical trials target Osteoporosis?
There are 12 clinical trials targeting Osteoporosis tracked by BioSniper.
What is the prevalence of Osteoporosis?
The estimated prevalence of Osteoporosis is approximately 7000.0 per 100,000 population.
Deep-dive into Osteoporosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis